That's right, and FDA studies can be posted before approval is met. That's one reason I argue its not necessarily a 6-9 month timeline. I agree with your argument first sales will come in February, if manufacturing launches soon.
We may actually agree more than we disagree. Again, I'm not arguing for $1 per share. I see it more likely in the 20-30 cent range, with initial sales. From there it depends what happens in the equine market and beyond. I want to see studies for diagnosing infection.
oh come on the guys havent even announced a sales PO or a distributor...manufacturer nothing. what evidence do you have to make that assumption? jmo they are wnot far from where they were last year before they had these issues with SL..
Market Data 
Markets 
AI
